Endoscopy 2015; 47(08): 696-702
DOI: 10.1055/s-0034-1391845
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis

Urban Arnelo
1   Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
2   Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Surgery, Karolinska Institutet, Stockholm, Sweden
,
Erik von Seth
1   Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
3   Department of Medicine, Karolinska Institutet, Stockholm, Sweden
,
Annika Bergquist
1   Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
3   Department of Medicine, Karolinska Institutet, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

submitted 17 June 2014

accepted after revision 19 January 2015

Publication Date:
31 March 2015 (online)

Background and study aims: The role of cholangioscopy in primary sclerosing cholangitis (PSC) using a single-operator peroral cholangioscopy direct visualization system is unknown. This study aimed to prospectively evaluate the clinical utility of the system in PSC patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).

Patients and methods: Patients with PSC or suspicion of PSC and a clinical indication for ERCP were enrolled between September 2008 and May 2011. Patients underwent cholangioscopy with sampling from biliary strictures. Clinical data, technical information from the ERCP procedure, and results from sampling by brush cytology and mini-forceps biopsy were collected. Long-term follow-up was conducted. Outcomes included technical success, sampling adequacy, and diagnostic accuracy of cholangioscopy-guided sampling for detection of cholangiocarcinoma (CCA).

Results: A total of 47 patients with PSC were included in the study. Median follow-up time was 27 months (range 2 – 64 months). Technical success was achieved in 96 % (45/47). In 9 % (4/45), the target lesion could not have been reached without the cholangioscopic visualization of the bile duct, which enabled further advancement of the investigation. A total of 64 biliary strictures were evaluated. Sample quality was adequate in 98 % (62/63) of the cytology brushings and in 95 % (21/22) of the mini-forceps biopsies. Of the three patients with a final diagnosis of CCA, one was diagnosed at the time of the investigation. The sensitivity, specificity, accuracy, and negative predictive value were 33 %, 100 %, 96 %, and 95 %, respectively.

Conclusion: Cholangioscopy and cholangioscopy-guided sampling can be utilized successfully in patients with PSC. Cholangioscopy enabled targeted biopsies to be taken and was able to pass otherwise inaccessible strictures, making it potentially valuable for the management of biliary strictures in patients with PSC.

Trial registered at ClinicalTrials.gov (NCT01556555).

 
  • References

  • 1 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267
  • 2 Charatcharoenwitthaya P, Enders FB, Halling KC et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-1117
  • 3 Tischendorf JJ, Kruger M, Trautwein C et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 2006; 38: 665-669
  • 4 Draganov PV, Lin T, Chauhan S et al. Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc 2011; 73: 971-979
  • 5 Chen YK, Pleskow DK. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc 2007; 65: 832-841
  • 6 Lindberg B, Arnelo U, Bergquist A et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002; 34: 909-916
  • 7 Rajaram R, Ponsioen CY, Majoie CB et al. Evaluation of a modified cholangiographic classification system for primary sclerosing cholangitis. Abdominal Imaging 2001; 26: 43-47
  • 8 Cotton PB, Eisen GM, Aabakken L et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
  • 9 Draganov PV, Chauhan S, Wagh MS et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc 2012; 75: 347-353
  • 10 Ramchandani M, Reddy DN, Gupta R et al. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study. Gastrointest Endosc 2011; 74: 511-519
  • 11 Azeem N, Gostout CJ, Knipschield M et al. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc 2014; 79: 773-779
  • 12 Siddiqui AA, Mehendiratta V, Jackson W et al. Identification of cholangiocarcinoma by using the Spyglass Spyscope system for peroral cholangioscopy and biopsy collection. Clin Gastroenterol Hepatol 2012; 10: 466-471
  • 13 Bangarulingam SY, Gossard AA, Petersen BT et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol 2009; 104: 855-860
  • 14 Etzel JP, Eng SC, Ko CW et al. Complications after ERCP in patients with primary sclerosing cholangitis. Gastrointest Endosc 2008; 67: 643-648